HomeInsightsStock Comparison

Parnax Lab Ltd vs Piramal Pharma Ltd Stock Comparison

Parnax Lab Ltd vs Piramal Pharma Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Parnax Lab Ltd is ₹ 125.5 as of 22 Jul 15:30.
  • The P/E Ratio of Parnax Lab Ltd changed from 15.7 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 325.4 on March 2025 . This represents a CAGR of -42.71% over 2 years.
  • The Market Cap of Parnax Lab Ltd changed from ₹ 10.3 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 29763 crore on March 2025 . This represents a CAGR of 53.90% over 3 years.
  • The revenue of Parnax Lab Ltd for the Mar '25 is ₹ 49.46 crore as compare to the Dec '24 revenue of ₹ 40.41 crore. This represent the growth of 22.4% The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the growth of 25.92%.
  • The ebitda of Parnax Lab Ltd for the Mar '25 is ₹ 7.06 crore as compare to the Dec '24 ebitda of ₹ 4.46 crore. This represent the growth of 58.3% The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the growth of 68.77%.
  • The net profit of Parnax Lab Ltd changed from ₹ 3.33 crore to ₹ 2.93 crore over 8 quarters. This represents a CAGR of -6.20% The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 153.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Parnax Lab Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 2.68 % on March 2025 . This represents a CAGR of -37.94% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Parnax Lab Ltd

  • Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982.
  • The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012.
  • The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations.
  • Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company.
  • With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products.

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

Parnax Lab Ltd News Hub

News

Parnax Lab to discuss results

Parnax Lab will hold a meeting of the Board of Directors of the Company on 27 May 2025. Po...

Read more

21 May 2025 13:01

News

Parnax Lab to declare Quarterly Results

Parnax Lab will hold a meeting of the Board of Directors of the Company on 10 February 202...

Read more

01 Feb 2025 12:25

News

Parnax Lab to convene board meeting

Parnax Lab will hold a meeting of the Board of Directors of the Company on 14 November 202...

Read more

08 Nov 2024 19:46

News

Parnax Lab to conduct AGM

Parnax Lab announced that the Annual General Meeting (AGM) of the company will be held on ...

Read more

18 Sep 2024 16:50

News

Parnax Lab announces board meeting date

Parnax Lab will hold a meeting of the Board of Directors of the Company on 14 August 2024....

Read more

07 Aug 2024 12:34

News

Parnax Lab schedules board meeting

Parnax Lab will hold a meeting of the Board of Directors of the Company on 30 May 2024 Pow...

Read more

25 May 2024 16:35

Piramal Pharma Ltd News Hub

News

Piramal Pharma to sell its decommissioned unit in MIDC, Thane for Rs 8.50 cr

Piramal Pharma announced that the Administrative Committee of the Board, at its meeting he...

Read more

22 Jul 2025 16:23

News

Piramal Pharma receives upgrade in LT credit ratings

Piramal Pharma announced that CARE has revised the credit ratings assigned to the company ...

Read more

21 Jul 2025 13:15

News

Piramal Pharma to announce Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 July 202...

Read more

19 Jul 2025 09:22

News

Piramal Pharma to conduct AGM

Piramal Pharma announced that the 5th Annual General Meeting(AGM) of the company will be h...

Read more

14 Jun 2025 14:54

News

Piramal Pharma's Aurora unit completes USFDA inspection

Piramal Pharma announced that the US FDA conducted a general GMP (Good Manufacturing Pract...

Read more

02 Jun 2025 16:21

News

Piramal Pharma's Canada facility gets zero USFDA observation

According to a regulatory filing, the inspection was carried out from 26 May 2025 to 30 Ma...

Read more

02 Jun 2025 11:16

SWOT Analysis Of Parnax Lab Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Parnax Lab Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Parnax Lab Ltd and Piramal Pharma Ltd

Which company has a larger market capitalization, Parnax Lab Ltd or Piramal Pharma Ltd?

Market cap of Parnax Lab Ltd is 144 Cr while Market cap of Piramal Pharma Ltd is 27,296 Cr

What are the key factors driving the stock performance of Parnax Lab Ltd and Piramal Pharma Ltd?

The stock performance of Parnax Lab Ltd and Piramal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Parnax Lab Ltd and Piramal Pharma Ltd?

As of July 22, 2025, the Parnax Lab Ltd stock price is INR ₹125.5. On the other hand, Piramal Pharma Ltd stock price is INR ₹205.35.

How do dividend payouts of Parnax Lab Ltd and Piramal Pharma Ltd compare?

To compare the dividend payouts of Parnax Lab Ltd and Piramal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions